Description

• In Hypercholesterolemia and prevention of cardiovascular disease
• In combined Hyperlipidemia for ideal results choose the preferred therapy
• In combination with fenofibrate statins enhance reduction of novel risk factor fibrinogen

Combination:

Atorvastatin IP 20 mg + Aspirin IP 75 mg Capsules

Reduces

• LDLC by 41%1
• Total cholesterol by 31% 1
• Triglycerides by 20% 1

Increases

Atorvastatin improves the lipoprotein profile and oxidative status in patients with type 2 diabetes ^2

• Atorvastatin has the most favorable risk-benefit ratio among statins due to
• Superior efficacy profile
• Equivalent safety’

Effective in a broadest range of patients:

• Hypercholesterolemia
• Mixed dyslipidemia
• Hypertriglyceridemia

Significantly improves:

• Lipid profiles
• Endothelial markers
• Inflammatory markers
• Insulin sensitivity